Michael Wang, MD, Professor, Department of Lymphoma and Myeloma @MDAndersonNews offers his impression of the pivotal clinical data that lead to the FDA approval of zanubrutinib.
Clinical Data That Lead to the FDA Approval of Zanubrutinib @MDAndersonNews
